Microchip (MCHP) Insider Files Form 144 for 10,000-Share Sale

Rhea-AI Filing Summary

Microchip Technology, Inc. (MCHP) filed a Form 144 notifying a proposed sale of 10,000 shares of common stock through Merrill Lynch at 2049 Century Park East, Los Angeles, to be sold on 08/25/2025 on NASDAQ. The filing shows an aggregate market value of $682,551.28 for the shares and reports 539,679,667 shares outstanding for the issuer. The securities to be sold were granted as restricted stock units (RSUs) from Microchip Technology on multiple dates: 07/30/2010 (2,047 shares), 08/18/2021 (1,674 shares), 08/22/2022 (1,296 shares), 08/19/2024 (2,492 shares), and 08/18/2025 (2,491 shares). The filer reports no securities sold in the past three months and includes the standard representation that no material nonpublic information is known.

Insights

Securities Analyst

TL;DR: Insider proposes a small sale of 10,000 shares via broker; transaction size is immaterial relative to outstanding shares.

The Form 144 notifies a proposed sale of 10,000 common shares valued at $682,551.28. Against the issuer's reported 539,679,667 outstanding shares, the lot represents roughly 0.0019% of outstanding shares, indicating a de minimis impact on market capitalization. The securities originate from RSU grants spanning 2010 through 2025, suggesting the shares are from compensation vesting events rather than open-market purchases. No sales in the past three months are reported, which reduces immediate signaling about recent insider liquidity patterns. Overall, the filing is routine and likely not material to valuation.

Corporate Governance Specialist

TL;DR: Routine compliance filing for planned sale of vested RSUs; no disclosure of material nonpublic information asserted by the signer.

The Form 144 documents compliance with Rule 144 for an intended sale executed through Merrill Lynch on 08/25/2025. The table of acquisitions shows awards classified as Stock Bonus (RSU) with acquisition dates and quantities explicitly listed, which is standard disclosure for officer/director/affiliate disposals. The filer affirms they are unaware of undisclosed material adverse information. From a governance perspective, the filing satisfies notification requirements and contains no additional governance issues or disclosures requiring further review.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 2049 Century Park East Suite 1200 Los Angeles CA 90036	10000	682551.28	539679667	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2010	Stock Bonus (RSU)	Microchip Technology, Inc.			2047	07/30/2010	N/A
Common	08/18/2021	Stock Bonus (RSU)	Microchip Technology, Inc.			1674	08/18/2021	N/A
Common	08/22/2022	Stock Bonus (RSU)	Microchip Technology, Inc.			1296	08/22/2022	N/A
Common	08/19/2024	Stock Bonus (RSU)	Microchip Technology, Inc.			2492	08/19/2024	N/A
Common	08/18/2025	Stock Bonus (RSU)	Microchip Technology, Inc.			2491	08/18/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Microchip Technology's (MCHP) Form 144 disclose?

The filing notifies a proposed sale of 10,000 common shares via Merrill Lynch on 08/25/2025, with an aggregate market value of $682,551.28.

How many shares outstanding does Microchip report in the Form 144?

The Form 144 reports 539,679,667 shares outstanding for the issuer.

What type of securities are being sold according to the Form 144?

The securities are Common shares that were acquired as Stock Bonus (RSU) grants on multiple dates between 07/30/2010 and 08/18/2025.

Who is the broker handling the proposed sale in the Form 144?

The proposed sale is to be executed through Merrill Lynch at their Los Angeles address as listed in the filing.

Did the filer report any securities sold in the past three months?

The filing states Nothing to Report for securities sold during the past three months.